"Dream weaver", "Visionary", "Maverick", plus #health + #QoL researcher // @ScHARRSheffield University of Sheffield, UK
Sheffield, United Kingdom
Joined January 2021
- Tweets642
- Following215
- Followers271
- Likes2.6K
Pinned Tweet
V. happy to share our paper describing a novel #PROM to assess the impact of #hypoglycaemia on people's #HRQoL. 3 years of rigorous development. Ready for use! Version for use in cost-effectiveness analysis coming soon! @HypoResolve @DiabetologiaJnl doi.org/10.1007/s00125-024-0…
I decided to join @LinkedIn last week. Extremely disappointed. They restricted my account after about a day, with no explanation and the support has been non-existent @LinkedInHelp. Never experienced anything like it… Guess I’ll stick to @ResearchGate
Interested in health economics, social preferences, and health technology assessment? Come do a PhD with global leaders in the field 👑 @donna_rowen Aki Tsuchiya @SCHARRSheffield
findaphd.com/phds/project/so…
Phil Powell 🦋 @philapowell.bsky.social retweeted
Happy New Year! 🥳🎆
We’ve got lots of exciting things planned for 2025, including new webinars taking place soon, the 9th Academy Meeting and 5th ECR Meeting in Q1.
Here’s our Comms Team giving a sneak peek of the location for the Academy and ECR Meetings - Barcelona! 🇪🇸👇
ALT 7 members of the EuroQol comms team pose in on the side of a busy road with cars driving. Behind them is the Place d’Espanya in Barcelona, Spain, underneath a clear blue sky.
The Hypo-RESOLVE QoL can be used to generate utilities directly for cost-effectiveness analyses of interventions for #hypoglycaemia - find out more: doi.org/10.1016/j.jval.2024.… @HypoResolve w/ @donna_rowen
Excited to share our publication @HypoResolve
We outline a new preference-weighted measure to generate utilities and quality-adjusted life years for #hypoglycemia (Hypo-RESOLVE QoL-8D). Led by @donna_rowen with @philapowell @McdoolEmily & @rich_norman
shorturl.at/j5YI7
This festive season, here’s a gift you need 🎁… Current guidelines for assessing understanding in #PROMs are insufficient. @vikki_gale presents a new, robust, evidence-based method: the comprehensibility continuum
💥 rdcu.be/d2KsP w/ @JillCarlton1. #QoL @SCHARRHEDS
Phil Powell 🦋 @philapowell.bsky.social retweeted
A Systematic Review and Quality Assessment of Cardiovascular Disease–Specific Health-Related Quality of Life Instruments: Part II Psychometric Properties @chepa @HEI_mcmaster @hvanspall sciencedirect.com/science/ar…
Phil Powell 🦋 @philapowell.bsky.social retweeted
Please consider submitting abstracts for our forthcoming UK & Ire EuroQol meeting. And pls pass on the message to colleagues who may be interested. Thanks
Phil Powell 🦋 @philapowell.bsky.social retweeted
Qualitative methods in response-shift research can provide an understanding of what it “looks like” in different patient populations and translate results to clinical experience. Excited to be a part of this team! @ISOQOL @HopkinsOrtho
tinyurl.com/5xenjsdu
Phil Powell 🦋 @philapowell.bsky.social retweeted
Health & Social Care Economics Group had a huge presence @ISOQOL in Germany, presented a range of impactful work on quality of life outcomes throughout the life course, from children to older people @FlindersCFI
@JulieRatcliff19
@JiaSONG59877915 @rachel_milte @diana_khanna
Phil Powell 🦋 @philapowell.bsky.social retweeted
@vikki_gale gave a phenomenal presentation today about her PhD research. Take home messages: 1) young children CAN provide evidence on item comprehensibility; 2) the Comprehensibility Continuum can be used to quantify and evidence understanding. @SCHARRSheffield @ISOQOL
Vikki (@vikki_gale) knockin’ it out the park with her presentation at #ISOQOL on methods to involve younger children in cognitive debriefing. Fantastic job! @SCHARRSheffield @JillCarlton1
Phil Powell 🦋 @philapowell.bsky.social retweeted
@philapowell presenting @ISOQOL summarized findings of a @EuroQol funded research exploring who should value health-related quality of life in children? Lots of interesting audience questions and more methods research needed! @SCHARRSheffield @SCHARRHEDS @SCHARR_KE
The outstanding @donna_rowen presenting comparative preferences from members of the public and people living with diabetes @ #ISOQOL. Funding from the international @HypoResolve project @SCHARRSheffield @JillCarlton1
Flying ✈️ to the EuroQol Plenary 2024. Looking forward to an engaging couple of days with colleagues
At the 41st EuroQol Plenary 2024, research presented in the scientific sessions will discuss a wide range of topics.
Get an early look at what they’ll discuss 👀 ⤵️
#EuroQolPlenary2024 #EQ5D #HealthEconomics
ALT Text lists 4 areas of discussion at the 41st EuroQol Plenary 2024 including psychometric properties of EQ-5D instruments, bolt-ons, valuation and application of EQ-5D in different settings.
Phil Powell 🦋 @philapowell.bsky.social retweeted
At the 41st EuroQol Plenary 2024, research presented in the scientific sessions will discuss a wide range of topics.
Get an early look at what they’ll discuss 👀 ⤵️
#EuroQolPlenary2024 #EQ5D #HealthEconomics
ALT Text lists 4 areas of discussion at the 41st EuroQol Plenary 2024 including psychometric properties of EQ-5D instruments, bolt-ons, valuation and application of EQ-5D in different settings.
Phil Powell 🦋 @philapowell.bsky.social retweeted
Is #ElonMusk's X a sinking ship? 🛳
As academic & civil society organisations question their presence on the platform, @Andy_Tattersall asks why research organisations might stay (or not) & what alternative #socialmedia they're exploring @LSEImpactBlog.
blogs.lse.ac.uk/impactofsoci…
Phil Powell 🦋 @philapowell.bsky.social retweeted
With 11K+ accesses over the last three months, it would appear people are interested in our review and results! In collaboration with @AstraZeneca and other colleagues at @SCHARRSheffield including @DanielPollard2
📚Excited to share our latest publication 'Direct and Indirect Costs of Breast Cancer and Associated Implications: A Systematic Review' by @DrMattFranklin and @DanielPollard2
💻Check out our paper in Advances in Therapy
doi.org/10.1007/s12325-024-0…
#systematicreview
PROQuALS is an exciting new outcome measure that assesses subjectively the HRQoL of people living with #MND, based on how much of a problem different aspects of life are / are not for that individual at that time. Expect updates soon📣
Happy to share our exciting new project developing a PRO to measure QoL for people living with MND. @philapowell
@profcjmcdermott @alysgriffiths_
@MNDoutcomes
@SCHARRSheffield @mndassoc @SCHARRHEDS
hqlo.biomedcentral.com/artic…
Phil Powell 🦋 @philapowell.bsky.social retweeted
Great to see this paper out online showing the impact of symptomatic and asymptomatic sensor hypoglycaemia from @uffehs @HypoResolve @EASDnews @DTN_UK @LDC_tweets @MadderJules @janespeight link.springer.com/article/10…
